Summary

The global Medical Glass Bottle market is projected to grow from US$ 7582 million in 2025 to US$ 10833 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Medical Glass Bottle refers to pharmaceutical glass bottles and vials designed as primary packaging that comes into direct contact with drug products. The market primarily covers molded glass bottles formed from molten-glass gobs and tubular glass bottles or vials converted from preformed glass tubing. Products may be manufactured from Type I borosilicate glass, Type II treated soda-lime-silica glass, Type III soda-lime-silica glass, or specialty high-performance compositions, and are supplied in clear or amber formats and in bulk or ready-to-use configurations. The research scope focuses on containers used for parenteral preparations, vaccines, biologics, lyophilized drugs, oral liquids, oral solids and related pharmaceutical formulations. Critical evaluation parameters include hydrolytic resistance, extractables and leachables, inner-surface durability, light transmission, dimensional accuracy, neck-finish consistency, particle and cosmetic defect levels, thermal-shock resistance, mechanical strength, container-closure integrity and compatibility with automated filling lines.
Key Findings
In 2025, global Medical Glass Bottle production reached approximately 42,597 M Units, with an average global market price of around US$ 178 per k unit.
This study identifies Asia Pacific as the largest production and consumption base by unit volume.
Tubular Type I glass vials lead premium injectable, biologic, and vaccine packaging applications.
Molded bottles retain scale advantages in oral medicines and larger pharmaceutical container formats.
Small-volume parenteral preparations form the value-leading downstream application segment.
Hydrolytic resistance, dimensional consistency, and container-closure integrity determine supplier qualification.
Market Trends
The medical glass bottle market is shifting from standardized containers toward high-performance drug-containment systems. Growth in biologics, antibody-drug conjugates, vaccines, cell and gene therapies, and lyophilized formulations is increasing demand for Type I tubular vials with improved chemical durability, low particle generation, and reliable performance during deep-cold storage. Ready-to-use vials supplied washed, depyrogenated, and sterilized in nests or trays are gaining importance because they reduce fill-finish preparation steps and support flexible, small-batch production. Product development is also moving toward internal barrier coatings, external low-friction coatings, strengthened glass, lightweight designs, amber formats for photosensitive drugs, and unit-level digital traceability. Corning’s product validation indicates that its coated vial technology can improve filling-line efficiency by 20%–50% and reduce glass particulates by up to 96% compared with conventional vials; these figures represent specific platform performance rather than market-wide averages. Automated optical inspection, dimensional measurement, and cosmetic-defect detection are becoming standard competitive capabilities. Regulatory development is placing greater emphasis on hydrolytic-resistance testing, spectral transmission, and product-specific suitability.
Market Dynamics
Drivers
Demand is supported by rising production of injectable generics, biologics, vaccines, and chronic-disease therapies, together with the expansion of contract development, manufacturing, and fill-finish capacity. Glass maintains a strong position in pharmaceutical primary packaging because of its transparency, gas-barrier performance, sterilization resistance, and established regulatory history. More complex and higher-value formulations require containers with tighter dimensional tolerances, stronger surface durability, lower particle generation, and improved container-closure integrity. Pharmaceutical companies are also adopting dual-sourcing strategies for critical packaging and developing regional supply chains, creating demand for qualified local producers capable of supplying Type I glass, ready-to-use formats, and complete vial-stopper-seal systems.
Restraints
Medical glass bottle demand is constrained by substitution from prefilled syringes, cartridges, flexible infusion bags, and cyclic olefin polymer or copolymer containers in applications where lower breakage risk, reduced weight, or integrated drug delivery is preferred. Glass furnaces are energy-intensive and require continuous operation, making production economics sensitive to natural-gas, electricity, soda ash, and borate costs. New glass compositions, coatings, manufacturing sites, and surface treatments must undergo lengthy drug-compatibility, stability, and regulatory qualification, limiting rapid supplier switching. Mature oral-liquid and commodity molded-bottle markets also face strong price competition and comparatively limited product differentiation.
Opportunities
The strongest opportunities lie in Type I tubular vials, ready-to-use packaging, coated and strengthened containers, ultra-low-temperature-compatible vials, and amber packaging for light-sensitive biologics. Suppliers can increase value capture by combining glass containers with compatible elastomer closures, aluminum seals, nest-and-tub systems, washing, sterilization, analytical testing, and regulatory documentation. Localization of neutral borosilicate tubing and high-quality vial conversion offers additional potential in China and other Asian pharmaceutical manufacturing centers. Smaller ready-to-use batches for clinical trials, personalized medicine, and contract fill-finish operations provide an attractive specialist market, while lightweight designs, greater cullet utilization, and lower-carbon furnaces create differentiation in pharmaceutical sustainability procurement.
Challenges
The central technical risks are delamination, surface-ion release, pH shift, extractables, glass particles, cracks, thermal-shock failure, and loss of container-closure integrity. These risks vary with drug formulation, sterilization process, storage period, and temperature, requiring product-specific qualification rather than reliance solely on pharmacopoeial glass classification. Manufacturers must maintain precise neck geometry, wall-thickness distribution, and batch consistency while controlling cosmetic defects at high production speeds. Capacity additions also require substantial capital, furnace expertise, and long customer-validation cycles. Supply disruptions involving pharmaceutical glass tubing, borates, energy, closures, or sterilization services can affect delivery reliability throughout the downstream fill-finish chain.
Industry Chain Analysis
The upstream chain includes silica sand, borates, soda ash, limestone, alumina, colorants, cullet, and specialty glass modifiers, together with refractories, molds, furnaces, glass-tubing lines, forming equipment, and automated inspection systems. Molded-container producers melt raw materials and form bottles directly from molten-glass gobs, whereas tubular-container producers convert glass tubing through heating, cutting, neck forming, bottom forming, and annealing. Midstream value creation arises from glass formulation, dimensional precision, surface treatment, coating, washing, depyrogenation, sterilization, clean packaging, automated inspection, and regulatory technical support. Downstream customers include pharmaceutical and biotechnology companies, vaccine manufacturers, generic-drug producers, CDMOs, diagnostic companies, and veterinary-drug manufacturers. Stoppers, aluminum seals, and closure systems form an adjacent supply chain, while container-closure compatibility and filling-line performance determine the value of the complete packaging system.
Segment Insights
The recommended primary classification is by manufacturing process: Molded Glass Bottles and Tubular Glass Bottles/Vials. Molded bottles are formed directly from molten glass and are well suited to oral liquids, oral solids, larger parenteral containers, and applications requiring mechanical robustness and cost-efficient high-volume production. They can be produced from Type I, Type II, or Type III glass, although their weight, wall-thickness variation, and dimensional tolerances are generally greater than those of tubular formats. Tubular bottles and vials are converted from continuously drawn glass tubing and provide tighter dimensional control, lower container weight, and strong compatibility with high-speed filling, lyophilization, and ready-to-use processing. Type I tubular vials consequently hold the leading position in premium injectable, vaccine, and biologic applications.
Glass class should be treated as a secondary classification covering Type I Borosilicate Glass, Type II Treated Soda-Lime-Silica Glass, Type III Soda-Lime-Silica Glass, and Specialty High-Performance Glass. Additional analytical dimensions may include Bulk versus Ready-to-Use, Clear versus Amber, Coated versus Uncoated, and Standard versus High-Strength Containers. This multidimensional framework prevents manufacturing process, material performance, and delivery format from being mixed within one classification.
Downstream Market Opportunities
Injectable solutions represent the largest volume-based application for medical glass bottles, with demand distributed between Type I tubular vials for small-volume parenterals and mechanically robust molded bottles for selected large-volume preparations. Vaccines, serum-derived products, and other biologics constitute the principal high-value opportunity because they require strong hydrolytic resistance, low particle generation, reliable container-closure integrity, and compatibility with cold-chain or ultra-low-temperature storage. Powder and lyophilized injectables create additional demand for dimensionally consistent tubular vials that can withstand freezing, vacuum drying, stoppering, and temperature cycling. Oral liquid preparations provide a stable volume base for clear and amber molded bottles, with growth opportunities linked to pediatric medicines, chronic-disease treatments, over-the-counter drugs, and tamper-evident dispensing systems. Other emerging applications include clinical-trial drugs, diagnostic reagents, veterinary medicines, oral solid preparations, and highly potent or photosensitive formulations. Suppliers offering Type I glass, ready-to-use processing, surface coatings, automated inspection, and compatible closure systems are positioned to capture higher-value demand across these applications.
Regional Insights
This study identifies Asia Pacific as the largest market by unit production and consumption, supported by the scale of pharmaceutical manufacturing in China, Japan, and other Asian economies. China has a broad molded- and tubular-container supply base and is upgrading toward neutral borosilicate tubing, Type I vials, automated inspection, and ready-to-use products. Japan retains strong capabilities in high-precision tubular conversion and pharmaceutical quality management, while Southeast Asian demand is increasingly supplied through regional production and qualified imports.
Europe has the highest concentration of established high-value glass technologies, including Type I tubing, ready-to-use vial systems, coatings, and integrated containment solutions. North America remains a major market for biologics, specialty injectables, and advanced fill-finish packaging, supported by high-performance glass development and regional vial conversion. Regional competition therefore differs materially: Asia emphasizes capacity, localization, and cost-effective qualification, while Europe and North America place greater weight on ready-to-use processing, specialty surfaces, regulatory support, and total filling-line economics.
Competitive Landscape Analysis
The global core manufacturer includes SCHOTT Pharma, Gerresheimer, SGD Pharma, Stevanato Group, Nipro PharmaPackaging, Corning, Shiotani Glass, and PGP Glass. Stoelzle Glass Group and Beatson Clark strengthen the supply of molded pharmaceutical bottles and oral-drug packaging, while DWK Life Sciences participates in the specialized market through WHEATON molded serum bottles, and Pacific Vial Manufacturing serves tubular and custom-vial requirements. Major Chinese manufacturers include Shandong Pharmaceutical Glass, Linuo Pharmaceutical Packaging, Cangzhou Four Stars Glass, Ningbo Zhengli Pharmaceutical Packaging, Chongqing Zhengchuan Pharmaceutical Packaging, and Triumph Junheng, together with Nantong Xinde, Anhui Huaxin, Shandong Dingxin, Taian Youlyy, Chengdu Jingu, and Jiyuan Zhengyu. Bormioli Pharma has been part of Gerresheimer since December 2024. West Pharmaceutical primarily provides elastomer closures, containment systems, and integrated glass-vial solutions. Competition centers on qualified glass classifications, drug compatibility, defect rates, dimensional consistency, coating technologies, automated inspection, ready-to-use processing, regulatory support, total delivered cost, and supply continuity. Given the differences among molded, tubular, specialty-glass, and oral-pharmaceutical packaging segments, a single industry-wide ranking is not appropriate.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Medical Glass Bottle market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
SCHOTT Pharma
Gerresheimer AG
SGD
Stevanato Group
Nipro Corporation
Corning
DWK Life Sciences
Shiotani Glass
Stoelzle Glass Group
PGP Glass
West Pharmaceutical
Daikyo Seiko
Radpharm Scientific
Pacific Vial Manufacturing
Shandong Pharmaceutical Glass
Linuo Pharmaceutical Packaging
CANGZHOU FOUR STARS GLASS
Nantong Xinde Medical Packing Material
Ningbo Zhengli Pharmaceutical Packaging
Chongqing Zhengchuan Pharmaceutical Packaging
Anhui Huaxin Pharmaceutical Glass Products
Shandong Dingxin Pharmaceutical Packaging Group
Jiyuan Zhengyu Industrial
Taian Youlyy Industrial
Chengdu Jingu Medicinal Packing
Triumph Junheng
Huaxing Glass
Segment by Type
Molded Glass Bottle
Tubular Glass Bottle
Segment by Glass Material
Sodium Calcium Glass Bottle
Low Borosilicate Glass Bottle
Medium Borosilicate Glass Bottle
High Borosilicate Glass Bottle
Segment by Capacity
Capacity≤30mL
Capacity 30-100mL
Capacity>100mL
Segment by Application
Injection
Vaccines
Serum
Oral Liquid
Powder Injection Agent
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Medical Glass Bottle study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Medical Glass Bottle: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Medical Glass Bottle Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Molded Glass Bottle
1.2.3 Tubular Glass Bottle
1.3 Market Segmentation by Glass Material
1.3.1 Global Medical Glass Bottle Market Size by Glass Material, 2021 vs 2025 vs 2032
1.3.2 Sodium Calcium Glass Bottle
1.3.3 Low Borosilicate Glass Bottle
1.3.4 Medium Borosilicate Glass Bottle
1.3.5 High Borosilicate Glass Bottle
1.4 Market Segmentation by Capacity
1.4.1 Global Medical Glass Bottle Market Size by Capacity, 2021 vs 2025 vs 2032
1.4.2 Capacity≤30mL
1.4.3 Capacity 30-100mL
1.4.4 Capacity>100mL
1.5 Market Segmentation by Application
1.5.1 Global Medical Glass Bottle Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Injection
1.5.3 Vaccines
1.5.4 Serum
1.5.5 Oral Liquid
1.5.6 Powder Injection Agent
1.5.7 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Medical Glass Bottle Revenue Estimates and Forecasts (2021-2032)
2.2 Global Medical Glass Bottle Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Medical Glass Bottle Sales Estimates and Forecasts (2021-2032)
2.4 Global Medical Glass Bottle Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Medical Glass Bottle Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Medical Glass Bottle Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Molded Glass Bottle: Market Share by Key Manufacturers
3.5.2 Tubular Glass Bottle: Market Share by Key Manufacturers
3.6 Global Medical Glass Bottle Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Medical Glass Bottle Sales Performance by Type
4.1.1 Global Medical Glass Bottle Sales Volume by Type (2021-2032)
4.1.2 Global Medical Glass Bottle Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Medical Glass Bottle Sales Performance by Glass Material
4.2.1 Global Medical Glass Bottle Sales Volume by Glass Material (2021-2032)
4.2.2 Global Medical Glass Bottle Revenue by Glass Material (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Glass Material (2021-2032)
4.3 Global Medical Glass Bottle Sales Performance by Capacity
4.3.1 Global Medical Glass Bottle Sales Volume by Capacity (2021-2032)
4.3.2 Global Medical Glass Bottle Revenue by Capacity (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Capacity (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Medical Glass Bottle Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Medical Glass Bottle Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Medical Glass Bottle Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Medical Glass Bottle Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Medical Glass Bottle Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Medical Glass Bottle Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Medical Glass Bottle Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Medical Glass Bottle Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Medical Glass Bottle Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Medical Glass Bottle Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Medical Glass Bottle Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Medical Glass Bottle Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 SCHOTT Pharma
11.1.1 SCHOTT Pharma Corporation Information
11.1.2 SCHOTT Pharma Business Overview
11.1.3 SCHOTT Pharma Medical Glass Bottle Product Models, Descriptions and Specifications
11.1.4 SCHOTT Pharma Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 SCHOTT Pharma Medical Glass Bottle Sales by Product in 2025
11.1.6 SCHOTT Pharma Medical Glass Bottle Sales by Application in 2025
11.1.7 SCHOTT Pharma Medical Glass Bottle Sales by Geographic Area in 2025
11.1.8 SCHOTT Pharma Medical Glass Bottle SWOT Analysis
11.1.9 SCHOTT Pharma Recent Developments
11.2 Gerresheimer AG
11.2.1 Gerresheimer AG Corporation Information
11.2.2 Gerresheimer AG Business Overview
11.2.3 Gerresheimer AG Medical Glass Bottle Product Models, Descriptions and Specifications
11.2.4 Gerresheimer AG Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Gerresheimer AG Medical Glass Bottle Sales by Product in 2025
11.2.6 Gerresheimer AG Medical Glass Bottle Sales by Application in 2025
11.2.7 Gerresheimer AG Medical Glass Bottle Sales by Geographic Area in 2025
11.2.8 Gerresheimer AG Medical Glass Bottle SWOT Analysis
11.2.9 Gerresheimer AG Recent Developments
11.3 SGD
11.3.1 SGD Corporation Information
11.3.2 SGD Business Overview
11.3.3 SGD Medical Glass Bottle Product Models, Descriptions and Specifications
11.3.4 SGD Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 SGD Medical Glass Bottle Sales by Product in 2025
11.3.6 SGD Medical Glass Bottle Sales by Application in 2025
11.3.7 SGD Medical Glass Bottle Sales by Geographic Area in 2025
11.3.8 SGD Medical Glass Bottle SWOT Analysis
11.3.9 SGD Recent Developments
11.4 Stevanato Group
11.4.1 Stevanato Group Corporation Information
11.4.2 Stevanato Group Business Overview
11.4.3 Stevanato Group Medical Glass Bottle Product Models, Descriptions and Specifications
11.4.4 Stevanato Group Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Stevanato Group Medical Glass Bottle Sales by Product in 2025
11.4.6 Stevanato Group Medical Glass Bottle Sales by Application in 2025
11.4.7 Stevanato Group Medical Glass Bottle Sales by Geographic Area in 2025
11.4.8 Stevanato Group Medical Glass Bottle SWOT Analysis
11.4.9 Stevanato Group Recent Developments
11.5 Nipro Corporation
11.5.1 Nipro Corporation Corporation Information
11.5.2 Nipro Corporation Business Overview
11.5.3 Nipro Corporation Medical Glass Bottle Product Models, Descriptions and Specifications
11.5.4 Nipro Corporation Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Nipro Corporation Medical Glass Bottle Sales by Product in 2025
11.5.6 Nipro Corporation Medical Glass Bottle Sales by Application in 2025
11.5.7 Nipro Corporation Medical Glass Bottle Sales by Geographic Area in 2025
11.5.8 Nipro Corporation Medical Glass Bottle SWOT Analysis
11.5.9 Nipro Corporation Recent Developments
11.6 Corning
11.6.1 Corning Corporation Information
11.6.2 Corning Business Overview
11.6.3 Corning Medical Glass Bottle Product Models, Descriptions and Specifications
11.6.4 Corning Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Corning Recent Developments
11.7 DWK Life Sciences
11.7.1 DWK Life Sciences Corporation Information
11.7.2 DWK Life Sciences Business Overview
11.7.3 DWK Life Sciences Medical Glass Bottle Product Models, Descriptions and Specifications
11.7.4 DWK Life Sciences Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 DWK Life Sciences Recent Developments
11.8 Shiotani Glass
11.8.1 Shiotani Glass Corporation Information
11.8.2 Shiotani Glass Business Overview
11.8.3 Shiotani Glass Medical Glass Bottle Product Models, Descriptions and Specifications
11.8.4 Shiotani Glass Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Shiotani Glass Recent Developments
11.9 Stoelzle Glass Group
11.9.1 Stoelzle Glass Group Corporation Information
11.9.2 Stoelzle Glass Group Business Overview
11.9.3 Stoelzle Glass Group Medical Glass Bottle Product Models, Descriptions and Specifications
11.9.4 Stoelzle Glass Group Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Stoelzle Glass Group Recent Developments
11.10 PGP Glass
11.10.1 PGP Glass Corporation Information
11.10.2 PGP Glass Business Overview
11.10.3 PGP Glass Medical Glass Bottle Product Models, Descriptions and Specifications
11.10.4 PGP Glass Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 PGP Glass Recent Developments
11.11 West Pharmaceutical
11.11.1 West Pharmaceutical Corporation Information
11.11.2 West Pharmaceutical Business Overview
11.11.3 West Pharmaceutical Medical Glass Bottle Product Models, Descriptions and Specifications
11.11.4 West Pharmaceutical Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 West Pharmaceutical Recent Developments
11.12 Daikyo Seiko
11.12.1 Daikyo Seiko Corporation Information
11.12.2 Daikyo Seiko Business Overview
11.12.3 Daikyo Seiko Medical Glass Bottle Product Models, Descriptions and Specifications
11.12.4 Daikyo Seiko Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Daikyo Seiko Recent Developments
11.13 Radpharm Scientific
11.13.1 Radpharm Scientific Corporation Information
11.13.2 Radpharm Scientific Business Overview
11.13.3 Radpharm Scientific Medical Glass Bottle Product Models, Descriptions and Specifications
11.13.4 Radpharm Scientific Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Radpharm Scientific Recent Developments
11.14 Pacific Vial Manufacturing
11.14.1 Pacific Vial Manufacturing Corporation Information
11.14.2 Pacific Vial Manufacturing Business Overview
11.14.3 Pacific Vial Manufacturing Medical Glass Bottle Product Models, Descriptions and Specifications
11.14.4 Pacific Vial Manufacturing Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Pacific Vial Manufacturing Recent Developments
11.15 Shandong Pharmaceutical Glass
11.15.1 Shandong Pharmaceutical Glass Corporation Information
11.15.2 Shandong Pharmaceutical Glass Business Overview
11.15.3 Shandong Pharmaceutical Glass Medical Glass Bottle Product Models, Descriptions and Specifications
11.15.4 Shandong Pharmaceutical Glass Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Shandong Pharmaceutical Glass Recent Developments
11.16 Linuo Pharmaceutical Packaging
11.16.1 Linuo Pharmaceutical Packaging Corporation Information
11.16.2 Linuo Pharmaceutical Packaging Business Overview
11.16.3 Linuo Pharmaceutical Packaging Medical Glass Bottle Product Models, Descriptions and Specifications
11.16.4 Linuo Pharmaceutical Packaging Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Linuo Pharmaceutical Packaging Recent Developments
11.17 CANGZHOU FOUR STARS GLASS
11.17.1 CANGZHOU FOUR STARS GLASS Corporation Information
11.17.2 CANGZHOU FOUR STARS GLASS Business Overview
11.17.3 CANGZHOU FOUR STARS GLASS Medical Glass Bottle Product Models, Descriptions and Specifications
11.17.4 CANGZHOU FOUR STARS GLASS Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 CANGZHOU FOUR STARS GLASS Recent Developments
11.18 Nantong Xinde Medical Packing Material
11.18.1 Nantong Xinde Medical Packing Material Corporation Information
11.18.2 Nantong Xinde Medical Packing Material Business Overview
11.18.3 Nantong Xinde Medical Packing Material Medical Glass Bottle Product Models, Descriptions and Specifications
11.18.4 Nantong Xinde Medical Packing Material Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Nantong Xinde Medical Packing Material Recent Developments
11.19 Ningbo Zhengli Pharmaceutical Packaging
11.19.1 Ningbo Zhengli Pharmaceutical Packaging Corporation Information
11.19.2 Ningbo Zhengli Pharmaceutical Packaging Business Overview
11.19.3 Ningbo Zhengli Pharmaceutical Packaging Medical Glass Bottle Product Models, Descriptions and Specifications
11.19.4 Ningbo Zhengli Pharmaceutical Packaging Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Ningbo Zhengli Pharmaceutical Packaging Recent Developments
11.20 Chongqing Zhengchuan Pharmaceutical Packaging
11.20.1 Chongqing Zhengchuan Pharmaceutical Packaging Corporation Information
11.20.2 Chongqing Zhengchuan Pharmaceutical Packaging Business Overview
11.20.3 Chongqing Zhengchuan Pharmaceutical Packaging Medical Glass Bottle Product Models, Descriptions and Specifications
11.20.4 Chongqing Zhengchuan Pharmaceutical Packaging Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Chongqing Zhengchuan Pharmaceutical Packaging Recent Developments
11.21 Anhui Huaxin Pharmaceutical Glass Products
11.21.1 Anhui Huaxin Pharmaceutical Glass Products Corporation Information
11.21.2 Anhui Huaxin Pharmaceutical Glass Products Business Overview
11.21.3 Anhui Huaxin Pharmaceutical Glass Products Medical Glass Bottle Product Models, Descriptions and Specifications
11.21.4 Anhui Huaxin Pharmaceutical Glass Products Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Anhui Huaxin Pharmaceutical Glass Products Recent Developments
11.22 Shandong Dingxin Pharmaceutical Packaging Group
11.22.1 Shandong Dingxin Pharmaceutical Packaging Group Corporation Information
11.22.2 Shandong Dingxin Pharmaceutical Packaging Group Business Overview
11.22.3 Shandong Dingxin Pharmaceutical Packaging Group Medical Glass Bottle Product Models, Descriptions and Specifications
11.22.4 Shandong Dingxin Pharmaceutical Packaging Group Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Shandong Dingxin Pharmaceutical Packaging Group Recent Developments
11.23 Jiyuan Zhengyu Industrial
11.23.1 Jiyuan Zhengyu Industrial Corporation Information
11.23.2 Jiyuan Zhengyu Industrial Business Overview
11.23.3 Jiyuan Zhengyu Industrial Medical Glass Bottle Product Models, Descriptions and Specifications
11.23.4 Jiyuan Zhengyu Industrial Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Jiyuan Zhengyu Industrial Recent Developments
11.24 Taian Youlyy Industrial
11.24.1 Taian Youlyy Industrial Corporation Information
11.24.2 Taian Youlyy Industrial Business Overview
11.24.3 Taian Youlyy Industrial Medical Glass Bottle Product Models, Descriptions and Specifications
11.24.4 Taian Youlyy Industrial Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 Taian Youlyy Industrial Recent Developments
11.25 Chengdu Jingu Medicinal Packing
11.25.1 Chengdu Jingu Medicinal Packing Corporation Information
11.25.2 Chengdu Jingu Medicinal Packing Business Overview
11.25.3 Chengdu Jingu Medicinal Packing Medical Glass Bottle Product Models, Descriptions and Specifications
11.25.4 Chengdu Jingu Medicinal Packing Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 Chengdu Jingu Medicinal Packing Recent Developments
11.26 Triumph Junheng
11.26.1 Triumph Junheng Corporation Information
11.26.2 Triumph Junheng Business Overview
11.26.3 Triumph Junheng Medical Glass Bottle Product Models, Descriptions and Specifications
11.26.4 Triumph Junheng Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Triumph Junheng Recent Developments
11.27 Huaxing Glass
11.27.1 Huaxing Glass Corporation Information
11.27.2 Huaxing Glass Business Overview
11.27.3 Huaxing Glass Medical Glass Bottle Product Models, Descriptions and Specifications
11.27.4 Huaxing Glass Medical Glass Bottle Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 Huaxing Glass Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Medical Glass Bottle Industry Chain
12.2 Medical Glass Bottle Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Medical Glass Bottle Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Medical Glass Bottle Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Medical Glass Bottle Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Medical Glass Bottle Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Medical Glass Bottle Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Medical Glass Bottle Market Size Growth Rate by Glass Material, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Medical Glass Bottle Market Size Growth Rate by Capacity, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Medical Glass Bottle Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Medical Glass Bottle Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Medical Glass Bottle Revenue by Region (US$ Million), 2021-2026
Table 7. Global Medical Glass Bottle Revenue by Region (US$ Million), 2027-2032
Table 8. Global Medical Glass Bottle Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (M Units)
Table 9. Global Medical Glass Bottle Sales by Region (M Units), 2021-2026
Table 10. Global Medical Glass Bottle Sales by Region (M Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Medical Glass Bottle Sales by Manufacturers (M Units), 2021-2026
Table 13. Global Medical Glass Bottle Sales Share by Manufacturers (2021-2026)
Table 14. Global Medical Glass Bottle Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Medical Glass Bottle Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Medical Glass Bottle Revenue, 2025
Table 18. Global Medical Glass Bottle Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Medical Glass Bottle Average Selling Price (ASP) by Manufacturers (US$/K Unit), 2021-2026
Table 20. Key Manufacturers Medical Glass Bottle Manufacturing Base and Headquarters
Table 21. Global Medical Glass Bottle Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Medical Glass Bottle Sales Volume by Type (M Units), 2021-2026
Table 25. Global Medical Glass Bottle Sales Volume by Type (M Units), 2027-2032
Table 26. Global Medical Glass Bottle Revenue by Type (US$ Million), 2021-2026
Table 27. Global Medical Glass Bottle Revenue by Type (US$ Million), 2027-2032
Table 28. Global Medical Glass Bottle Sales Volume by Glass Material (M Units), 2021-2026
Table 29. Global Medical Glass Bottle Sales Volume by Glass Material (M Units), 2027-2032
Table 30. Global Medical Glass Bottle Revenue by Glass Material (US$ Million), 2021-2026
Table 31. Global Medical Glass Bottle Revenue by Glass Material (US$ Million), 2027-2032
Table 32. Global Medical Glass Bottle Sales Volume by Capacity (M Units), 2021-2026
Table 33. Global Medical Glass Bottle Sales Volume by Capacity (M Units), 2027-2032
Table 34. Global Medical Glass Bottle Revenue by Capacity (US$ Million), 2021-2026
Table 35. Global Medical Glass Bottle Revenue by Capacity (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Medical Glass Bottle Sales by Application (M Units), 2021-2026
Table 38. Global Medical Glass Bottle Sales by Application (M Units), 2027-2032
Table 39. Medical Glass Bottle High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Medical Glass Bottle Revenue by Application (US$ Million), 2021-2026
Table 41. Global Medical Glass Bottle Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Medical Glass Bottle Growth Accelerators and Market Barriers
Table 45. North America Medical Glass Bottle Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Medical Glass Bottle Sales (M Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Medical Glass Bottle Growth Accelerators and Market Barriers
Table 48. Europe Medical Glass Bottle Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Medical Glass Bottle Sales (M Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Medical Glass Bottle Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Medical Glass Bottle Sales (M Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Medical Glass Bottle Growth Accelerators and Market Barriers
Table 53. Southeast Asia Medical Glass Bottle Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Medical Glass Bottle Investment Opportunities and Key Challenges
Table 55. Central and South America Medical Glass Bottle Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Medical Glass Bottle Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Medical Glass Bottle Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. SCHOTT Pharma Corporation Information
Table 59. SCHOTT Pharma Description and Major Businesses
Table 60. SCHOTT Pharma Product Models, Descriptions and Specifications
Table 61. SCHOTT Pharma Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 62. SCHOTT Pharma Sales Value Proportion by Product in 2025
Table 63. SCHOTT Pharma Sales Value Proportion by Application in 2025
Table 64. SCHOTT Pharma Sales Value Proportion by Geographic Area in 2025
Table 65. SCHOTT Pharma Medical Glass Bottle SWOT Analysis
Table 66. SCHOTT Pharma Recent Developments
Table 67. Gerresheimer AG Corporation Information
Table 68. Gerresheimer AG Description and Major Businesses
Table 69. Gerresheimer AG Product Models, Descriptions and Specifications
Table 70. Gerresheimer AG Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 71. Gerresheimer AG Sales Value Proportion by Product in 2025
Table 72. Gerresheimer AG Sales Value Proportion by Application in 2025
Table 73. Gerresheimer AG Sales Value Proportion by Geographic Area in 2025
Table 74. Gerresheimer AG Medical Glass Bottle SWOT Analysis
Table 75. Gerresheimer AG Recent Developments
Table 76. SGD Corporation Information
Table 77. SGD Description and Major Businesses
Table 78. SGD Product Models, Descriptions and Specifications
Table 79. SGD Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 80. SGD Sales Value Proportion by Product in 2025
Table 81. SGD Sales Value Proportion by Application in 2025
Table 82. SGD Sales Value Proportion by Geographic Area in 2025
Table 83. SGD Medical Glass Bottle SWOT Analysis
Table 84. SGD Recent Developments
Table 85. Stevanato Group Corporation Information
Table 86. Stevanato Group Description and Major Businesses
Table 87. Stevanato Group Product Models, Descriptions and Specifications
Table 88. Stevanato Group Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 89. Stevanato Group Sales Value Proportion by Product in 2025
Table 90. Stevanato Group Sales Value Proportion by Application in 2025
Table 91. Stevanato Group Sales Value Proportion by Geographic Area in 2025
Table 92. Stevanato Group Medical Glass Bottle SWOT Analysis
Table 93. Stevanato Group Recent Developments
Table 94. Nipro Corporation Corporation Information
Table 95. Nipro Corporation Description and Major Businesses
Table 96. Nipro Corporation Product Models, Descriptions and Specifications
Table 97. Nipro Corporation Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 98. Nipro Corporation Sales Value Proportion by Product in 2025
Table 99. Nipro Corporation Sales Value Proportion by Application in 2025
Table 100. Nipro Corporation Sales Value Proportion by Geographic Area in 2025
Table 101. Nipro Corporation Medical Glass Bottle SWOT Analysis
Table 102. Nipro Corporation Recent Developments
Table 103. Corning Corporation Information
Table 104. Corning Description and Major Businesses
Table 105. Corning Product Models, Descriptions and Specifications
Table 106. Corning Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 107. Corning Recent Developments
Table 108. DWK Life Sciences Corporation Information
Table 109. DWK Life Sciences Description and Major Businesses
Table 110. DWK Life Sciences Product Models, Descriptions and Specifications
Table 111. DWK Life Sciences Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 112. DWK Life Sciences Recent Developments
Table 113. Shiotani Glass Corporation Information
Table 114. Shiotani Glass Description and Major Businesses
Table 115. Shiotani Glass Product Models, Descriptions and Specifications
Table 116. Shiotani Glass Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 117. Shiotani Glass Recent Developments
Table 118. Stoelzle Glass Group Corporation Information
Table 119. Stoelzle Glass Group Description and Major Businesses
Table 120. Stoelzle Glass Group Product Models, Descriptions and Specifications
Table 121. Stoelzle Glass Group Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 122. Stoelzle Glass Group Recent Developments
Table 123. PGP Glass Corporation Information
Table 124. PGP Glass Description and Major Businesses
Table 125. PGP Glass Product Models, Descriptions and Specifications
Table 126. PGP Glass Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 127. PGP Glass Recent Developments
Table 128. West Pharmaceutical Corporation Information
Table 129. West Pharmaceutical Description and Major Businesses
Table 130. West Pharmaceutical Product Models, Descriptions and Specifications
Table 131. West Pharmaceutical Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 132. West Pharmaceutical Recent Developments
Table 133. Daikyo Seiko Corporation Information
Table 134. Daikyo Seiko Description and Major Businesses
Table 135. Daikyo Seiko Product Models, Descriptions and Specifications
Table 136. Daikyo Seiko Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 137. Daikyo Seiko Recent Developments
Table 138. Radpharm Scientific Corporation Information
Table 139. Radpharm Scientific Description and Major Businesses
Table 140. Radpharm Scientific Product Models, Descriptions and Specifications
Table 141. Radpharm Scientific Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 142. Radpharm Scientific Recent Developments
Table 143. Pacific Vial Manufacturing Corporation Information
Table 144. Pacific Vial Manufacturing Description and Major Businesses
Table 145. Pacific Vial Manufacturing Product Models, Descriptions and Specifications
Table 146. Pacific Vial Manufacturing Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 147. Pacific Vial Manufacturing Recent Developments
Table 148. Shandong Pharmaceutical Glass Corporation Information
Table 149. Shandong Pharmaceutical Glass Description and Major Businesses
Table 150. Shandong Pharmaceutical Glass Product Models, Descriptions and Specifications
Table 151. Shandong Pharmaceutical Glass Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 152. Shandong Pharmaceutical Glass Recent Developments
Table 153. Linuo Pharmaceutical Packaging Corporation Information
Table 154. Linuo Pharmaceutical Packaging Description and Major Businesses
Table 155. Linuo Pharmaceutical Packaging Product Models, Descriptions and Specifications
Table 156. Linuo Pharmaceutical Packaging Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 157. Linuo Pharmaceutical Packaging Recent Developments
Table 158. CANGZHOU FOUR STARS GLASS Corporation Information
Table 159. CANGZHOU FOUR STARS GLASS Description and Major Businesses
Table 160. CANGZHOU FOUR STARS GLASS Product Models, Descriptions and Specifications
Table 161. CANGZHOU FOUR STARS GLASS Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 162. CANGZHOU FOUR STARS GLASS Recent Developments
Table 163. Nantong Xinde Medical Packing Material Corporation Information
Table 164. Nantong Xinde Medical Packing Material Description and Major Businesses
Table 165. Nantong Xinde Medical Packing Material Product Models, Descriptions and Specifications
Table 166. Nantong Xinde Medical Packing Material Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 167. Nantong Xinde Medical Packing Material Recent Developments
Table 168. Ningbo Zhengli Pharmaceutical Packaging Corporation Information
Table 169. Ningbo Zhengli Pharmaceutical Packaging Description and Major Businesses
Table 170. Ningbo Zhengli Pharmaceutical Packaging Product Models, Descriptions and Specifications
Table 171. Ningbo Zhengli Pharmaceutical Packaging Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 172. Ningbo Zhengli Pharmaceutical Packaging Recent Developments
Table 173. Chongqing Zhengchuan Pharmaceutical Packaging Corporation Information
Table 174. Chongqing Zhengchuan Pharmaceutical Packaging Description and Major Businesses
Table 175. Chongqing Zhengchuan Pharmaceutical Packaging Product Models, Descriptions and Specifications
Table 176. Chongqing Zhengchuan Pharmaceutical Packaging Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 177. Chongqing Zhengchuan Pharmaceutical Packaging Recent Developments
Table 178. Anhui Huaxin Pharmaceutical Glass Products Corporation Information
Table 179. Anhui Huaxin Pharmaceutical Glass Products Description and Major Businesses
Table 180. Anhui Huaxin Pharmaceutical Glass Products Product Models, Descriptions and Specifications
Table 181. Anhui Huaxin Pharmaceutical Glass Products Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 182. Anhui Huaxin Pharmaceutical Glass Products Recent Developments
Table 183. Shandong Dingxin Pharmaceutical Packaging Group Corporation Information
Table 184. Shandong Dingxin Pharmaceutical Packaging Group Description and Major Businesses
Table 185. Shandong Dingxin Pharmaceutical Packaging Group Product Models, Descriptions and Specifications
Table 186. Shandong Dingxin Pharmaceutical Packaging Group Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 187. Shandong Dingxin Pharmaceutical Packaging Group Recent Developments
Table 188. Jiyuan Zhengyu Industrial Corporation Information
Table 189. Jiyuan Zhengyu Industrial Description and Major Businesses
Table 190. Jiyuan Zhengyu Industrial Product Models, Descriptions and Specifications
Table 191. Jiyuan Zhengyu Industrial Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 192. Jiyuan Zhengyu Industrial Recent Developments
Table 193. Taian Youlyy Industrial Corporation Information
Table 194. Taian Youlyy Industrial Description and Major Businesses
Table 195. Taian Youlyy Industrial Product Models, Descriptions and Specifications
Table 196. Taian Youlyy Industrial Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 197. Taian Youlyy Industrial Recent Developments
Table 198. Chengdu Jingu Medicinal Packing Corporation Information
Table 199. Chengdu Jingu Medicinal Packing Description and Major Businesses
Table 200. Chengdu Jingu Medicinal Packing Product Models, Descriptions and Specifications
Table 201. Chengdu Jingu Medicinal Packing Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 202. Chengdu Jingu Medicinal Packing Recent Developments
Table 203. Triumph Junheng Corporation Information
Table 204. Triumph Junheng Description and Major Businesses
Table 205. Triumph Junheng Product Models, Descriptions and Specifications
Table 206. Triumph Junheng Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 207. Triumph Junheng Recent Developments
Table 208. Huaxing Glass Corporation Information
Table 209. Huaxing Glass Description and Major Businesses
Table 210. Huaxing Glass Product Models, Descriptions and Specifications
Table 211. Huaxing Glass Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026)
Table 212. Huaxing Glass Recent Developments
Table 213. Key Raw Materials Distribution
Table 214. Raw Materials Key Suppliers
Table 215. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 216. Milestones in Production Technology Evolution
Table 217. Distributors List
Table 218. Market Trends and Market Evolution
Table 219. Market Drivers and Opportunities
Table 220. Market Challenges, Risks, and Restraints
Table 221. Research Programs/Design for This Report
Table 222. Key Data Information from Secondary Sources
Table 223. Key Data Information from Primary Sources

List of Figures
Figure 1. Medical Glass Bottle Product Picture
Figure 2. Global Medical Glass Bottle Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Molded Glass Bottle Product Picture
Figure 4. Tubular Glass Bottle Product Picture
Figure 5. Global Medical Glass Bottle Market Size Growth Rate by Glass Material, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Sodium Calcium Glass Bottle Product Picture
Figure 7. Low Borosilicate Glass Bottle Product Picture
Figure 8. Medium Borosilicate Glass Bottle Product Picture
Figure 9. High Borosilicate Glass Bottle Product Picture
Figure 10. Global Medical Glass Bottle Market Size Growth Rate by Capacity, 2021 vs 2025 vs 2032 (US$ Million)
Figure 11. Capacity≤30mL Product Picture
Figure 12. Capacity 30-100mL Product Picture
Figure 13. Capacity>100mL Product Picture
Figure 14. Global Medical Glass Bottle Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Injection
Figure 16. Vaccines
Figure 17. Serum
Figure 18. Oral Liquid
Figure 19. Powder Injection Agent
Figure 20. Other
Figure 21. Medical Glass Bottle Report Years Considered
Figure 22. Global Medical Glass Bottle Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 24. Global Medical Glass Bottle Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 25. Global Medical Glass Bottle Revenue-Based Market Share by Region (2021-2032)
Figure 26. Global Medical Glass Bottle Sales (M Units), 2021-2032
Figure 27. Global Medical Glass Bottle Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (M Units)
Figure 28. Global Medical Glass Bottle Sales Market Share by Region (2021-2032)
Figure 29. Top 5 and Top 10 Manufacturers Medical Glass Bottle Sales Volume Market Share in 2025
Figure 30. Global Medical Glass Bottle Revenue-Based Market Share Ranking (2025)
Figure 31. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 32. Molded Glass Bottle Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Tubular Glass Bottle Revenue-Based Market Share by Manufacturer in 2025
Figure 34. Global Medical Glass Bottle Sales Volume-Based Market Share by Type (2021-2032)
Figure 35. Global Medical Glass Bottle Revenue-Based Market Share by Type (2021-2032)
Figure 36. Global Medical Glass Bottle ASP by Type (US$/K Unit), 2021-2032
Figure 37. Global Medical Glass Bottle Sales Volume-Based Market Share by Glass Material (2021-2032)
Figure 38. Global Medical Glass Bottle Revenue-Based Market Share by Glass Material (2021-2032)
Figure 39. Global Medical Glass Bottle ASP by Glass Material (US$/K Unit), 2021-2032
Figure 40. Global Medical Glass Bottle Sales Volume-Based Market Share by Capacity (2021-2032)
Figure 41. Global Medical Glass Bottle Revenue-Based Market Share by Capacity (2021-2032)
Figure 42. Global Medical Glass Bottle ASP by Capacity (US$/K Unit), 2021-2032
Figure 43. Global Medical Glass Bottle Sales Market Share by Application (2021-2032)
Figure 44. Global Medical Glass Bottle Revenue-Based Market Share by Application (2021-2032)
Figure 45. Global Medical Glass Bottle ASP by Application (US$/K Unit), 2021-2032
Figure 46. North America Medical Glass Bottle Sales YoY (M Units), 2021-2032
Figure 47. North America Medical Glass Bottle Revenue YoY (US$ Million), 2021-2032
Figure 48. North America Top 5 Manufacturers Medical Glass Bottle Sales Revenue (US$ Million) in 2025
Figure 49. North America Medical Glass Bottle Sales Volume (M Units) by Application (2021-2032)
Figure 50. North America Medical Glass Bottle Sales Revenue (US$ Million) by Application (2021-2032)
Figure 51. US Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 52. Canada Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 53. Mexico Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 54. Europe Medical Glass Bottle Sales YoY (M Units), 2021-2032
Figure 55. Europe Medical Glass Bottle Revenue YoY (US$ Million), 2021-2032
Figure 56. Europe Top 5 Manufacturers Medical Glass Bottle Sales Revenue (US$ Million) in 2025
Figure 57. Europe Medical Glass Bottle Sales Volume (M Units) by Application (2021-2032)
Figure 58. Europe Medical Glass Bottle Sales Revenue (US$ Million) by Application (2021-2032)
Figure 59. Germany Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 60. France Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 61. U.K. Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 62. Italy Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 63. Russia Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 64. Asia-Pacific Medical Glass Bottle Sales YoY (M Units), 2021-2032
Figure 65. Asia-Pacific Medical Glass Bottle Revenue YoY (US$ Million), 2021-2032
Figure 66. Asia-Pacific Top 8 Manufacturers Medical Glass Bottle Sales Revenue (US$ Million) in 2025
Figure 67. Asia-Pacific Medical Glass Bottle Sales Volume (M Units) by Application (2021-2032)
Figure 68. Asia-Pacific Medical Glass Bottle Sales Revenue (US$ Million) by Application (2021-2032)
Figure 69. Indonesia Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 70. Japan Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 71. South Korea Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 72. China Taiwan Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 73. India Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 74. Central and South America Medical Glass Bottle Sales YoY (M Units), 2021-2032
Figure 75. Central and South America Medical Glass Bottle Revenue YoY (US$ Million), 2021-2032
Figure 76. Central and South America Top 5 Manufacturers Medical Glass Bottle Sales Revenue (US$ Million) in 2025
Figure 77. Central and South America Medical Glass Bottle Sales Volume (M Units) by Application (2021-2032)
Figure 78. Central and South America Medical Glass Bottle Sales Revenue (US$ Million) by Application (2021-2032)
Figure 79. Brazil Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 80. Argentina Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 81. Middle East, and Africa Medical Glass Bottle Sales YoY (M Units), 2021-2032
Figure 82. Middle East and Africa Medical Glass Bottle Revenue YoY (US$ Million), 2021-2032
Figure 83. Middle East and Africa Top 5 Manufacturers Medical Glass Bottle Sales Revenue (US$ Million) in 2025
Figure 84. Middle East and Africa Medical Glass Bottle Sales Volume (M Units) by Application (2021-2032)
Figure 85. Middle East and Africa Medical Glass Bottle Sales Revenue (US$ Million) by Application (2021-2032)
Figure 86. GCC Countries Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 87. Turkey Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 88. Egypt Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 89. South Africa Medical Glass Bottle Revenue (US$ Million), 2021-2032
Figure 90. Medical Glass Bottle Industry Chain Mapping
Figure 91. Regional Medical Glass Bottle Manufacturing Base Distribution (%)
Figure 92. Global Medical Glass Bottle Production Market Share by Region (2021-2032)
Figure 93. Medical Glass Bottle Production Process
Figure 94. Regional Medical Glass Bottle Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed